A new US rule creates more room for reformulation from 14 December 2026, subject to a dairy qualification. Start by identifying the standard that applies to your product.
The US Food and Drug Administration has issued a final rule allowing salt substitutes in standardised foods whose standards of identity specify salt as a required or optional ingredient. The agency announced the change on 9 October; the rule was published in the Federal Register on 13 October. Its general effective date is 14 December 2026. FDA announcement; final rule and dates
Three dates, one qualification
The date comes with a qualification. The rule provides for a stay of the dairy standards-of-identity provisions to which proper objections are filed. Teams working on an affected dairy product therefore need to check the applicable provision and its status, rather than assume that every part takes effect together. Final rule, Dates and section VI
The formulation work still needs a brief
A standard of identity sets requirements for a food sold under a particular name. Changing those requirements can remove a constraint on formulation. It does not establish that a proposed substitute works in a particular product, or create a blanket authorisation for ingredients. The rule expressly leaves the relevant food-additive requirements in place. Final rule, section III
FoodEdge proposes a short scope check before committing development resources:
- Name the product and the US standard of identity that applies.
- Identify the proposed substitute and the conditions of its intended use.
- Check which amended provision applies and whether it is effective for that product.
- Ask the responsible regulatory and technical specialists what evidence the formulation and label will need.
The useful output is a product-specific development brief, with unresolved questions assigned to an owner. This is a working prompt, not a complete compliance checklist.
FoodEdge's proposed next step is to compare the reformulated product with an agreed reference across the properties that matter for its intended use. Those may include sensory performance, processing, stability and the applicable label requirements. The precise programme depends on the product; the announcement does not supply it.
Before relying on the change, revisit the final rule and any subsequent FDA or Federal Register notice concerning the relevant provision. A stay or amendment would change the timetable for that product. Keep the regulatory date and the formulation validation decision on separate lines in the brief.
Source check: 17 October 2026. Geography: United States. Desk-based news with clearly identified editorial interpretation. This is a scoping summary, not a complete compliance procedure.
Based on linked public sources, with AI-assisted research and preparation. Approved for publication by FoodEdge’s Editor-in-Chief.
